A Medical Device Daily

Edwards Lifesciences (Irvine, California) reported that its board of directors has approved a two-for-one split of the company's outstanding shares of common stock to be effected in the form of a 100% stock dividend.

Stockholders of record at the close of business on May 14 will be issued one additional share of common stock for each share owned as of that date. The additional shares will be distributed on May 27. The stock split will increase the number of common shares outstanding from nearly 57 million shares to about 114 million shares.